Over One-Third of U.S. Adults Report More Than One Sunburn in Previous 12 Months
via HealthDayTUESDAY, June 2, 2026 -- More than one-third of U.S. adults report at least one sunburn during the previous 12 months, according to research published in the May 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Dawn M. Holman, M.P.H., from the CDC in Atlanta, and colleagues describe the prevalence of one or more and four or more sunburns among U.S. adults during the previous 12 months using data from the 2024 National Health Interview Survey sample adult questionnaire.
The researchers found that an estimated 88.1 million (35.1 percent) and 18.8 million (7.5 percent) U.S. adults had at least one sunburn and had four or more sunburns, respectively, during the previous 12 months. Spending time in, on, or near the water was the most frequently reported context of the most recent sunburn among adults who experienced sunburn in the previous year (60.6 percent), followed by exercising, drinking alcohol, intentionally tanning, and working at their job (24.7, 17.6, 15.9, and 12.9 percent, respectively). About half (55.1 percent) reported that the most recent sunburn occurred despite sunscreen use.
"Measures to adapt, tailor, and expand existing evidence-based sun safety interventions might help prevent sunburns and reduce the risk for skin cancer," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-06-03 10:40
Read more
- No Causal Link Found for Aluminum-Adjuvanted Vaccines, Serious Health Outcomes
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
- A Single Dose of Lilly's PCSK9 Base Editor, VERVE-102, Reduced PCSK9 by up to 88% and LDL-C by up to 62%, with Durable Effects Supporting its Potential as a One-Time Treatment for Hypercholesterolemia
- Ivermectin Prescriptions Doubled After Mel Gibson Cancer Cure Claim
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions